Modern Family Star Eric Stonestreet & His Mom, a Two Time Cancer Survivor, Join Forces to Raise Awareness of Immuno-Oncology ...
May 05 2016 - 7:30AM
Business Wire
- Ready. Raise. Rise. creates a
social movement to honor cancer patients and caregivers and helps
provide charitable donations to advocacy organizations
- Bristol-Myers Squibb and Eric
Stonestreet call on anyone touched by cancer to raise and share a
virtual flag to support the cancer community
The Ready. Raise. Rise. campaign encourages everyone to
raise and share a flag to salute those who have been touched by
cancer, especially patients and caregivers, and learn more about a
rapidly evolving area of research, Immuno-Oncology, which seeks to
harness the body’s own immune system to fight cancer. For the
campaign’s second year, Eric Stonestreet of television’s hit comedy
“Modern Family” and films “Confirmation” and “The Secret Life of
Pets” is joined by his mother Jamey, who faced and survived cancer
twice. Bristol-Myers Squibb sponsors the campaign, which inspired
people to raise more than 50,000 flags last year, and this year
will make charitable donations to 23 participating cancer support
groups on behalf of flag raisers.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160505005186/en/
This press release has an accompanying Smart Marketing Page
providing further details about the organization, products and
services introduced below. You can access the Smart Marketing Page
via the following link:
http://smp.newshq.businesswire.com/pages/modern-family-star-eric-stonestreet-and-his-mom-two-time-cancer-survivor-join-forces-raise-awa.
“My mom has survived cancer twice, so I have personal reasons
for standing with Ready. Raise. Rise. again this year – It
gives me a chance to say how much I admire heroes like her, and at
the same time it allows me to learn about promising research in the
fight against cancer, like Immuno-Oncology. And participating in
the campaign also supports cancer advocacy groups that are helping
others like my mom,” said Eric Stonestreet. “So mom and I are
asking you to be Ready to Raise a virtual flag and Rise in
celebration of patients, caregivers and anyone else you know whose
life is touched by cancer.”
With more than 32 million people living with cancer worldwide,
nearly every family is impacted by cancer. Stonestreet is asking
people to go to ReadyRaiseRise.com to create and share a
flag in honor of someone who has been affected by cancer – whether
it be themselves, a loved one or a caregiver. Each person who
raises a flag can select one of 23 cancer advocacy organizations
they wish to support and share their flag on social media using the
hashtag #RaiseYourFlag. For each flag raised and shared, the
selected organization will receive a charitable donation from
Bristol-Myers Squibb. The company will distribute up to a total of
$150,000 in charitable donations across participating
organizations. Both Stonestreet and his mother are featured in a
public service announcement to further extend the reach of the
educational information about Immuno-Oncology research.
“Immuno-Oncology is an innovative area of research that may be
changing the way we approach cancer,” said Sanjiv Agarwala, MD,
chief of medical oncology and hematology at St. Luke’s Cancer
Center in Bethlehem, PA, and professor of medicine at Temple
University School of Medicine in Philadelphia, PA. “I’m passionate
about educating the cancer community about Immuno-Oncology research
as it explores a different way to approach cancer treatment, and
that may allow patients with advanced cancer the potential to lead
longer lives.”
“Ready. Raise. Rise. continues to resonate with the
cancer community, further motivating us to relentlessly pursue
Immuno-Oncology research and make a difference for patients,” said
Teresa Bitetti, senior vice president, U.S. Oncology, Bristol-Myers
Squibb. “Our ultimate goal with Immuno-Oncology is to improve
survival and quality of life for patients living with various types
of cancer, and this program provides an inspiring platform to honor
patients and caregivers in a meaningful way.”
Immuno-Oncology at Bristol-Myers Squibb
Bristol-Myers Squibb is leading research in an innovative field
of cancer research and treatment known as Immuno-Oncology, which
involves agents whose primary mechanism is to work directly with
the body’s immune system to fight cancer. The company is exploring
a variety of compounds and immunotherapeutic approaches for
patients with different types of cancer, including researching the
potential of combining Immuno-Oncology agents that target different
pathways in the treatment of cancer.
Bristol-Myers Squibb is committed to advancing the science of
Immuno-Oncology, with the goal of changing survival expectations
and the way patients live with cancer.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube and Facebook.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160505005186/en/
Media:Bristol-Myers SquibbLaurel Sacks,
609-897-2944Laurel.sacks@bms.comorCarrie Fernandez,
609-897-4957Carrie.fernandez@bms.comorChristine Hanson,
917-634-0608Christine.ennishanson@ogilvy.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024